1
|
Margiotti K, Fabiani M, Cima A, Libotte F, Mesoraca A, Giorlandino C. Prenatal Diagnosis by Trio Clinical Exome Sequencing: Single Center Experience. Curr Issues Mol Biol 2024; 46:3209-3217. [PMID: 38666931 PMCID: PMC11048976 DOI: 10.3390/cimb46040201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2024] [Revised: 03/28/2024] [Accepted: 04/03/2024] [Indexed: 04/28/2024] Open
Abstract
Fetal anomalies, characterized by structural or functional abnormalities occurring during intrauterine life, pose a significant medical challenge, with a notable prevalence, affecting approximately 2-3% of live births and 20% of spontaneous miscarriages. This study aims to identify the genetic cause of ultrasound anomalies through clinical exome sequencing (CES) analysis. The focus is on utilizing CES analysis in a trio setting, involving the fetuses and both parents. To achieve this objective, prenatal trio clinical exome sequencing was conducted in 51 fetuseses exhibiting ultrasound anomalies with previously negative results from chromosomal microarray (CMA) analysis. The study revealed pathogenic variants in 24% of the analyzed cases (12 out of 51). It is worth noting that the findings include de novo variants in 50% of cases and the transmission of causative variants from asymptomatic parents in 50% of cases. Trio clinical exome sequencing stands out as a crucial tool in advancing prenatal diagnostics, surpassing the effectiveness of relying solely on chromosomal microarray analysis. This underscores its potential to become a routine diagnostic standard in prenatal care, particularly for cases involving ultrasound anomalies.
Collapse
Affiliation(s)
- Katia Margiotti
- Human Genetics Lab, Altamedica Main Centre, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.C.); (F.L.); (A.M.); (C.G.)
| | - Marco Fabiani
- Human Genetics Lab, Altamedica Main Centre, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.C.); (F.L.); (A.M.); (C.G.)
| | - Antonella Cima
- Human Genetics Lab, Altamedica Main Centre, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.C.); (F.L.); (A.M.); (C.G.)
| | - Francesco Libotte
- Human Genetics Lab, Altamedica Main Centre, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.C.); (F.L.); (A.M.); (C.G.)
| | - Alvaro Mesoraca
- Human Genetics Lab, Altamedica Main Centre, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.C.); (F.L.); (A.M.); (C.G.)
| | - Claudio Giorlandino
- Human Genetics Lab, Altamedica Main Centre, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.C.); (F.L.); (A.M.); (C.G.)
- Fetal-Maternal Medical Centre, Altamedica Viale Liegi 45, 00198 Rome, Italy
| |
Collapse
|
2
|
Margiotti K, Monaco F, Fabiani M, Mesoraca A, Giorlandino C. EPIGENETIC CLOCKS: IN AGING-RELATED AND COMPLEX DISEASES. Cytogenet Genome Res 2023:000534561. [PMID: 37899027 DOI: 10.1159/000534561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Accepted: 10/02/2023] [Indexed: 10/31/2023] Open
Abstract
There is evidence that complex disease and mortality are associated with DNA methylation (DNAm) and age acceleration. Numerous epigenetic clocks, including Horvath, Hannum, DNA PhenoAge, DNA GrimAge, and DunedinPoAm continue to be developed in this young scientific field. The most well-known epigenetic clocks are presented here, along with information about how they relate to chronic disease. We examined all the literature until January 2023, investigating associations between measures of age acceleration and complex and age-related diseases. We focused on the scientific literature and researches that are most strongly associated with epigenetic clocks and that have shown promise as biomarkers for obesity, cardiovascular illness, type 2 diabetes, and neurodegenerative disease. Understanding the complex interactions between accelerated epigenetic clocks and chronic diseases may have significant effects on both the early diagnosis of disease and health promotion. Additionally, there is a lot of interest in developing treatment plans that can delay the onset of illnesses or, at the very least, alter the underlying causes of such disorders.
Collapse
|
3
|
Fabiani M, Margiotti K, Monaco F, Viola A, Cima A, Mesoraca A, Giorlandino C. Dynamics of SARS-CoV-2-Specific B Cell Memory Responses in Infected and Vaccinated Individuals. Viral Immunol 2023. [PMID: 37140898 DOI: 10.1089/vim.2022.0197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/05/2023] Open
Abstract
Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rapidly resulted in a pandemic constituting a global health emergency. As an indicator of long-term immune protection from reinfection with the SARS-CoV-2 virus, the presence of memory B cells (MBCs) should be evaluated. Since the beginning of COVID-19 pandemic, several variants of concerns have been detected, including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1/B.1.1.28.1), Delta (B.1.617.2), and Omicron (BA.1) variants with several different mutations, causing serious concern regarding the increased frequency of reinfection, and limiting the effectiveness of the vaccine response. At this regard, we investigated SARS-CoV-2-specific cellular immune responses in four different cohorts: COVID-19, COVID-19 infected and vaccinated, vaccinated, and negative subjects. We found that MBC response to SARS-CoV-2 at more than 11 months postinfection was higher in the peripheral blood of all COVID-19 infected and vaccinated subjects respect to all the other groups. Moreover, to better characterize the differences of SARS-CoV-2 variants immune responses, we genotyped SARS-CoV-2-positive samples from the patients' cohort. We found a higher level of immunoglobulin M+ (IgM+) and IgG+ spike MBCs in SARS-CoV-2-positive patients (5-8 months after symptoms onset) infected with the SARS-CoV-2-Delta variant compared with the SARS-CoV-2-Omicron variant implying a higher immune memory response. Our findings showed that MBCs persist more than 11 months after primary infection indicating a different involvement of the immune system according to the different SARS-CoV-2 variant that infected the host.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Claudio Giorlandino
- Human Genetics Lab, Altamedica, Rome, Italy
- Department of Prenatal Diagnosis, Fetal-Maternal Medical Centre, Altamedica, Rome, Italy
| |
Collapse
|
4
|
Aprile A, Calì G, Chianchiano N, Chiappa V, Corbella P, D'Addario V, Dall'Asta A, De Robertis V, Exacustos C, Familiari A, Fichera A, Formigoni C, Frusca T, Ghi T, Guerriero S, Iuculano A, Labate F, Martinelli P, Monni G, Morlano M, Nonino F, Olivieri C, Paladini D, Peddes C, Prefumo F, Rizzo G, Rustico M, Sarno L, Sciacovelli I, Sciarrone A, Stampalija T, Taddei F, Todros T, Valensise H, Vergani P, Volpe N, Volpe P, Votino C, Bettoncelli G, Bracalente G, Collini Ceccatelli M, Costantini M, D'Aloia A, Ferrazzi E, Giorlandino C, Locci M, Verrotti di Pianella C, Viora E, Zoia R, Bilardo K, Vicar M. Corrigendum to "The Italian guidelines on ultrasound in obstetrics and gynecology: Executive summary of recommendations for practice" [Eur. J. Obstetrics Gynecol. 279 (2022) 176-182]. Eur J Obstet Gynecol Reprod Biol 2023; 281:85-86. [PMID: 36584523 DOI: 10.1016/j.ejogrb.2022.12.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Anna Aprile
- Complex Operative Unit of Legal Medicine and Toxicology AOP, D.M.M. University of Padua, Italy
| | - Giuseppe Calì
- Department of Obstetrics and Gynecology, Maternal Fetal Medicine Unit, AO Villa Sofia/Cervello, Palermo, Italy
| | - Nicola Chianchiano
- Fetal Medicine Unit, Bucchieri La Ferla-Fatebenefratelli Hospital, Palermo, Italy
| | - Valentina Chiappa
- Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
| | - Paola Corbella
- Maternal Infant Department SC, Obstetrics and Gynecology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | | | - Andrea Dall'Asta
- Department of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Parma, Italy
| | | | - Caterina Exacustos
- Academic Department of Surgical Sciences, University of Rome "Tor Vergata", Italy
| | - Alessandra Familiari
- Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
| | - Anna Fichera
- Department of Clinical and Experimental Sciences, University of Brescia, Italy
| | | | - Tiziana Frusca
- Department of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Parma, Italy
| | - Tullio Ghi
- Department of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Parma, Italy
| | - Stefano Guerriero
- Department of Obstetrics and Gynecology, University of Cagliari, Policlinico Universitario Duilio Casula, Cagliari, Italy
| | - Ambra Iuculano
- Pathophysiology of Human Reproduction and Prenatal Diagnosis, Microcythemia Hospital Unit "A. CaO", ARNAS Brotzu, Cagliari, Italy
| | - Francesco Labate
- Department of Obstetrics and Gynecology, Maternal Fetal Medicine Unit, AO Villa Sofia/Cervello, Palermo, Italy
| | | | - Giovanni Monni
- Pathophysiology of Human Reproduction and Prenatal Diagnosis, Microcythemia Hospital Unit "A. CaO", ARNAS Brotzu, Cagliari, Italy
| | - Maddalena Morlano
- Department of Woman, Child and General and Specialized Surgery, Obstetrics and Gynecology Unit, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Francesco Nonino
- Operative Unit of Epidemiology and Statistics, IRCCS Institute of Neurological Sciences, Bologna, Italy
| | - Claudiana Olivieri
- Fetal Medicine Unit, Di Venere and Sarcone Hospitals, ASL BA, Bari, Italy
| | - Dario Paladini
- Complex Operative Unit of Maternal-Fetal Risk Pregnancy, G. Gaslini Institute, Genova, Italy
| | - Cristina Peddes
- Pathophysiology of Human Reproduction and Prenatal Diagnosis, Microcythemia Hospital Unit "A. CaO", ARNAS Brotzu, Cagliari, Italy
| | - Federico Prefumo
- Obstetrics and Gynecology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
| | - Giuseppe Rizzo
- Unità Operativa Complessa di Ginecologia ed Ostetricia Fondazione Policlinico Tor Vergata, Italy
| | - Mariangela Rustico
- Prenatal Diagnosis and Fetal Therapy "Umberto Nicolini", Hospital "V. Buzzi", Milan, Italy
| | - Laura Sarno
- Gynaecology and Obstetrics, University of Naples Federico II, Italy
| | - Irene Sciacovelli
- Gynecology and Obstetrics, Rovereto and Trento Hospitals, ASST, Trento, Italy
| | - Andrea Sciarrone
- Obstetrics and Gynecological Ultrasound and Prenatal Diagnosis Center, Citta' della Salute e della Scienza, Torino, Italy
| | - Tamara Stampalija
- Unit of Fetal Medicine and Prenatal Diagnosis, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, University of Trieste, Italy
| | - Fabrizio Taddei
- Gynecology and Obstetrics, Rovereto and Trento Hospitals, ASST, Trento, Italy
| | - Tullia Todros
- Professor of Gynaecology and Obstetrics, University of Torino, Italy
| | - Herbert Valensise
- Operative Unit of Gynaecology and Obstetrics, Casilino Polyclinic, University of Rome "Tor Vergata", Italy
| | | | - Nicola Volpe
- Department of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Parma, Italy
| | - Paolo Volpe
- Fetal Medicine Unit, Di Venere and Sarcone Hospitals, ASL BA, Bari, Italy
| | - Carmela Votino
- Fetal Medicine Unit, Di Venere and Sarcone Hospitals, ASL BA, Bari, Italy
| | - Germano Bettoncelli
- Councillor of the Medical Association and Head of the Culture Commission of the Board of Physicians of Brescia, Italy
| | | | | | | | | | - Enrico Ferrazzi
- Obstetrics and Gynaecological Clinic, IRCCS Foundation, Ca' Granda Hospital Maggiore Policlinico of Milan, University of Milan, SIGO Delegate, Italy
| | | | | | | | - Elsa Viora
- Gynaecology and Obstetrics, Turin, President of AOGOI, Italy
| | - Riccardo Zoia
- Legal Medicine and Insurance, University of Milan, President of the Italian Society of Legal Medicine, Italy
| | | | - Maria Vicar
- Midwife, Department of Obstetrics of the University Consortium Universalus, Naples, past President of FNOPO, Italy
| |
Collapse
|
5
|
Libotte F, Fabiani M, Margiotti K, Carpineto LS, Monaco F, Raffio R, Mesoraca A, Giorlandino C. De novo 3q13.13q21.2 interstitial deletion and paternal 12p13.3 microdeletion in a fetus with dysplasia of the corpus callosum and ventriculomegaly: A case report. Exp Ther Med 2023; 25:100. [PMID: 36761008 PMCID: PMC9893219 DOI: 10.3892/etm.2023.11799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Accepted: 11/30/2022] [Indexed: 01/18/2023] Open
Abstract
Chromosome 3q syndrome is a well-known genetic condition caused by interstitial deletion in the long arm of chromosome 3. The phenotype of this syndrome is variable and the great variability in the extent of these deletions leads to a wide spectrum of clinical manifestations. Terminal 12p deletion represents one of the rarest subtelomeric imbalances; patients with distal monosomy 12p present different phenotypes ranging from muscular hypotonia to autism spectrum disorders. The present study reported a prenatal diagnosis of a male fetus presenting ultrasound evidence of corpus callosum dysplasia and ventriculomegaly showing a 3q13q21.2 deletion and a 12p13.33 microdeletion paternally inherited. Among several features previously attributed to the terminal deletion of 3q, corpus callosum dysplasia and ventriculomegaly have rarely been reported together. As the 12p13.33 microdeletion in the father was associated only with muscular hypotonia and joint laxity, the involvement of terminal 12p deletions in the clinical features of the fetus was not possible to verify during the prenatal period. The present case report may provide a reference for prenatal diagnosis and genetic counseling in patients who present 3q13q21.2 deletions and 12p13.33 microdeletion.
Collapse
Affiliation(s)
- Francesco Libotte
- Human Genetics Laboratory, Fetal-Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy
| | - Marco Fabiani
- Human Genetics Laboratory, Fetal-Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy
| | - Katia Margiotti
- Human Genetics Laboratory, Fetal-Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy,Correspondence to: Dr Katia Margiotti, Human Genetics Laboratory, ALTAMEDICA, 45 Viale Liegi, 00198 Rome, Italy
| | | | - Francesca Monaco
- Human Genetics Laboratory, Fetal-Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy
| | - Raffaella Raffio
- Human Genetics Laboratory, Fetal-Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy
| | - Alvaro Mesoraca
- Human Genetics Laboratory, Fetal-Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy
| | - Claudio Giorlandino
- Human Genetics Laboratory, Fetal-Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy,Department of Prenatal Diagnosis, Fetal-Maternal Medical Centre, ALTAMEDICA, 00198 Rome, Italy
| |
Collapse
|
6
|
Fabiani M, Libotte F, Margiotti K, Tannous DKI, Sparacino D, D’Aleo MP, Monaco F, Dello Russo C, Mesoraca A, Giorlandino C. Agnathia-Otocephaly Complex Due to a De Novo Deletion in the OTX2 Gene. Genes (Basel) 2022; 13:genes13122269. [PMID: 36553536 PMCID: PMC9778614 DOI: 10.3390/genes13122269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Revised: 11/29/2022] [Accepted: 11/30/2022] [Indexed: 12/05/2022] Open
Abstract
Agnathia-otocephaly complex (AOC) is a rare and usually lethal malformation typically characterized by hypoplasia or the absence of the mandible, ventromedial and caudal displacement of the ears with or without the fusion of the ears, a small oral aperture with or without a tongue hypoplasia. Its incidence is reported as 1 in 70,000 births and its etiology has been attributed to both genetic and teratogenic causes. AOC is characterized by a wide severity clinical spectrum even when occurring within the same family, ranging from a mild mandibular defect to an extreme facial aberration incompatible with life. Most AOC cases are due to a de novo sporadic mutation. Given the genetic heterogeneity, many genes have been reported to be implicated in this disease but to date, the link to only two genes has been confirmed in the development of this complex: the orthodenticle homeobox 2 (OTX2) gene and the paired related homeobox 1 (PRRX1) gene. In this article, we report a case of a fetus with severe AOC, diagnosed in routine ultrasound scan in the first trimester of pregnancy. The genetic analysis showed a novel 10 bp deletion mutation c.766_775delTTGGGTTTTA in the OTX2 gene, which has never been reported before, together with a missense variant c.778T>C in cis conformation.
Collapse
Affiliation(s)
- Marco Fabiani
- ALTAMEDICA, Human Genetics Laboratory, Viale Liegi 45, 00198 Rome, Italy
| | - Francesco Libotte
- ALTAMEDICA, Human Genetics Laboratory, Viale Liegi 45, 00198 Rome, Italy
| | - Katia Margiotti
- ALTAMEDICA, Human Genetics Laboratory, Viale Liegi 45, 00198 Rome, Italy
- Correspondence: ; Tel.: +39-06-85058961
| | - Dina Khader Issa Tannous
- School of Medicine and Surgery, Department of Obstetrics and Gynecology, UniCamillus-Saint Camillus International University of Health Sciences, Via di Sant’Alessandro, 8, 00131 Rome, Italy
| | - Davide Sparacino
- ALTAMEDICA, Human Genetics Laboratory, Viale Liegi 45, 00198 Rome, Italy
| | - Maria Pia D’Aleo
- ALTAMEDICA, Human Genetics Laboratory, Viale Liegi 45, 00198 Rome, Italy
| | - Francesca Monaco
- ALTAMEDICA, Human Genetics Laboratory, Viale Liegi 45, 00198 Rome, Italy
| | | | - Alvaro Mesoraca
- ALTAMEDICA, Human Genetics Laboratory, Viale Liegi 45, 00198 Rome, Italy
| | - Claudio Giorlandino
- ALTAMEDICA, Human Genetics Laboratory, Viale Liegi 45, 00198 Rome, Italy
- ALTAMEDICA, Department of Prenatal Diagnosis, Fetal-Maternal Medical Centre, Altamedica Viale Liegi 45, 00198 Rome, Italy
| |
Collapse
|
7
|
Margiotti K, Fabiani M, Mesoraca A, Giorlandino C. Letter to the Editor: The Clinical Features of SARS-CoV-2 Infection Are Becoming Milder with Limited Symptomatic Effects. Viral Immunol 2022; 35:345-346. [PMID: 35580073 DOI: 10.1089/vim.2022.0009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Katia Margiotti
- ALTAMEDICA, Human Genetics Lab, Altamedica Main Centre, Rome, Italy
| | - Marco Fabiani
- ALTAMEDICA, Human Genetics Lab, Altamedica Main Centre, Rome, Italy
| | - Alvaro Mesoraca
- ALTAMEDICA, Human Genetics Lab, Altamedica Main Centre, Rome, Italy
| | - Claudio Giorlandino
- ALTAMEDICA, Human Genetics Lab, Altamedica Main Centre, Rome, Italy.,ALTAMEDICA, Department of Prenatal Diagnosis, Fetal-Maternal Medical Centre, Rome, Italy
| |
Collapse
|
8
|
Fabiani M, Margiotti K, Sabatino M, Viola A, Mesoraca A, Giorlandino C. A Rapid and Consistent Method to Identify Four SARS-CoV-2 Variants during the First Half of 2021 by RT-PCR. Vaccines (Basel) 2022; 10:vaccines10030483. [PMID: 35335115 PMCID: PMC8954379 DOI: 10.3390/vaccines10030483] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2022] [Revised: 03/11/2022] [Accepted: 03/18/2022] [Indexed: 01/02/2023] Open
Abstract
Since 2020, the COVID-19 pandemic has spread worldwide, causing health, economic, and social distress. Containment strategies rely on rapid and consistent methodology for molecular detection and characterization. Emerging variants of concern (VOCs) are currently associated with increased infectivity and immune escape (natural defence mechanisms and vaccine). Several VOCs have been detected, including Alpha variant (B.1.1.7), Beta variant (B.1.351), Gamma variant (P.1/B.1.1.28.1) and Delta variant (B.1.617.2), first identified in the UK, South Africa, Brazil and India, respectively. Here, a rapid and low-cost technique was validated to distinguish the Alpha, Beta, Gamma, and Delta SARS-CoV-2 variants by detecting spike gene mutations using a real-time reverse transcription polymerase chain reaction methodology (RT-PCR). A total of 132 positive patients affected by coronavirus disease-19 (COVID-19) were analysed by employing RT-PCR to target single-nucleotide polymorphisms (SNPs) to screen spike protein mutations. All data were validated by the next-generation sequencing (NGS) methodology and using sequences from a public database. Among 132 COVID-19-positive samples, we were able to discriminate all of the investigated SARS-CoV-2 variants with 100% concordance when compared with the NGS method. RT-PCR -based assays for identifying circulating VOCs of SARS-CoV-2 resulted in a rapid method used to identify specific SARS-CoV-2 variants, allowing for a better survey of the spread of the virus and its transmissibility in the pandemic phase.
Collapse
Affiliation(s)
- Marco Fabiani
- ALTAMEDICA, Human Genetics, Viale Liegi 45, 00198 Rome, Italy; (K.M.); (A.V.); (A.M.); (C.G.)
- Correspondence: ; Tel.: +39-06-8505961
| | - Katia Margiotti
- ALTAMEDICA, Human Genetics, Viale Liegi 45, 00198 Rome, Italy; (K.M.); (A.V.); (A.M.); (C.G.)
| | - Manuela Sabatino
- Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University, Piazzale Aldo Moro 5, 00185 Rome, Italy;
| | - Antonella Viola
- ALTAMEDICA, Human Genetics, Viale Liegi 45, 00198 Rome, Italy; (K.M.); (A.V.); (A.M.); (C.G.)
| | - Alvaro Mesoraca
- ALTAMEDICA, Human Genetics, Viale Liegi 45, 00198 Rome, Italy; (K.M.); (A.V.); (A.M.); (C.G.)
| | - Claudio Giorlandino
- ALTAMEDICA, Human Genetics, Viale Liegi 45, 00198 Rome, Italy; (K.M.); (A.V.); (A.M.); (C.G.)
- ALTAMEDICA, Fetal-Maternal Medical Centre, Department of Prenatal Diagnosis, Viale Liegi 45, 00198 Rome, Italy
| |
Collapse
|
9
|
Margiotti K, Fabiani M, Mesoraca A, Giorlandino C. Survey of fully vaccinated anti-COVID 19 people from June to November 2021: Single Italian centre study. J Med Virol 2022; 94:2919-2920. [PMID: 35238050 PMCID: PMC9088643 DOI: 10.1002/jmv.27690] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2022] [Revised: 02/01/2022] [Accepted: 02/28/2022] [Indexed: 11/22/2022]
Affiliation(s)
- Katia Margiotti
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Viale Liegi 45, 00198, Rome, Italy
| | - Marco Fabiani
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Viale Liegi 45, 00198, Rome, Italy
| | - Alvaro Mesoraca
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Viale Liegi 45, 00198, Rome, Italy
| | - Claudio Giorlandino
- ALTAMEDICA Department of Genetics, Altamedica Fetal Medical Centre, Rome, Italy
| |
Collapse
|
10
|
Margiotti K, Fabiani M, Mesoraca A, Giorlandino C. Natural immune response and protection from SARS-CoV-2 reinfection. Acta Virol 2021; 65:333-338. [PMID: 34796710 DOI: 10.4149/av_2021_401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the associated disease Coronavirus Disease 2019 (COVID-19) continues to spread throughout the world, causing millions of infections and dead. One major question in predicting the course of the COVID-19 pandemic is how well and how long the immune response protect the host from reinfection. Although more studies are needed, evidence suggests that virus-specific B cell response in people with SARS-CoV-2 infection is rapidly generated and seems to be more reliable marker of long-lasting humoral responses than serum antibodies. Here we reviewed all related major studies of immune response to SARS-CoV-2 virus to better understand the natural protection against the virus, and the risk of reinfection. The ability of our community to eradicate this virus mostly will depend on our knowledge on the immune response, critical not only for vaccine development and distribution but also for therapeutic options. Keywords.
Collapse
|
11
|
Cirillo PDR, Margiotti K, Fabiani M, Barros-Filho MC, Sparacino D, Cima A, Longo SA, Cupellaro M, Mesoraca A, Giorlandino C. Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection. PLoS One 2021; 16:e0255804. [PMID: 34352040 PMCID: PMC8341627 DOI: 10.1371/journal.pone.0255804] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Accepted: 07/25/2021] [Indexed: 11/25/2022] Open
Abstract
Advanced ovarian cancer is one of the most lethal gynecological tumor, mainly due to late diagnoses and acquired drug resistance. MicroRNAs (miRNAs) are small-non coding RNA acting as tumor suppressor/oncogenes differentially expressed in normal and epithelial ovarian cancer and has been recognized as a new class of tumor early detection biomarkers as they are released in blood fluids since tumor initiation process. Here, we evaluated by droplet digital PCR (ddPCR) circulating miRNAs in serum samples from healthy (N = 105) and untreated ovarian cancer patients (stages I to IV) (N = 72), grouped into a discovery/training and clinical validation set with the goal to identify the best classifier allowing the discrimination between earlier ovarian tumors from health controls women. The selection of 45 candidate miRNAs to be evaluated in the discovery set was based on miRNAs represented in ovarian cancer explorative commercial panels. We found six miRNAs showing increased levels in the blood of early or late-stage ovarian cancer groups compared to healthy controls. The serum levels of miR-320b and miR-141-3p were considered independent markers of malignancy in a multivariate logistic regression analysis. These markers were used to train diagnostic classifiers comprising miRNAs (miR-320b and miR-141-3p) and miRNAs combined with well-established ovarian cancer protein markers (miR-320b, miR-141-3p, CA-125 and HE4). The miRNA-based classifier was able to accurately discriminate early-stage ovarian cancer patients from health-controls in an independent sample set (Sensitivity = 80.0%, Specificity = 70.3%, AUC = 0.789). In addition, the integration of the serum proteins in the model markedly improved the performance (Sensitivity = 88.9%, Specificity = 100%, AUC = 1.000). A cross-study validation was carried out using four data series obtained from Gene Expression Omnibus (GEO), corroborating the performance of the miRNA-based classifier (AUCs ranging from 0.637 to 0.979). The clinical utility of the miRNA model should be validated in a prospective cohort in order to investigate their feasibility as an ovarian cancer early detection tool.
Collapse
Affiliation(s)
| | - Katia Margiotti
- Altamedica Center, Human Genetics Laboratories, Altamedica Main Center, Rome, Italy
- * E-mail:
| | - Marco Fabiani
- Altamedica Center, Human Genetics Laboratories, Altamedica Main Center, Rome, Italy
| | - Mateus C. Barros-Filho
- Department of Head and Neck Surgery, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
| | - David Sparacino
- Altamedica Center, Human Genetics Laboratories, Altamedica Main Center, Rome, Italy
| | - Antonella Cima
- Altamedica Center, Human Genetics Laboratories, Altamedica Main Center, Rome, Italy
| | - Salvatore A. Longo
- Altamedica Center, Human Genetics Laboratories, Altamedica Main Center, Rome, Italy
| | - Marina Cupellaro
- Altamedica, Department of Biochemistry, Altamedica Main Centre, Rome, Italy
| | - Alvaro Mesoraca
- Altamedica Center, Human Genetics Laboratories, Altamedica Main Center, Rome, Italy
| | - Claudio Giorlandino
- Altamedica Center, Human Genetics Laboratories, Altamedica Main Center, Rome, Italy
- Altamedica, Department of Biochemistry, Altamedica Main Centre, Rome, Italy
- Altamedica, Department of Prenatal Diagnosis, Fetal-Maternal Medical Center, Rome, Italy
| |
Collapse
|
12
|
Fabiani M, Margiotti K, Viola A, Mesoraca A, Giorlandino C. Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man. Pathogens 2021; 10:pathogens10050614. [PMID: 34067881 PMCID: PMC8156209 DOI: 10.3390/pathogens10050614] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Revised: 05/07/2021] [Accepted: 05/15/2021] [Indexed: 11/16/2022] Open
Abstract
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) continue to spread throughout the world, causing more than 120 million infections. Several variants of concern (VOCs) have emerged and spread with implications for vaccine efficacy, therapeutic antibody treatments, and possible reinfections. On 17 March 2021, several VOCs were detected, including lineage B.1.1.7, first identified in the UK, B.1.351 in South Africa, Lineage P.1 (B.1.1.28.1) in Brazil, and novel Sub-Lineage A (A.23.1), reported in Uganda, and B.1.525, reported in Nigeria. Here, we describe an 83-year-old man infected with the SARS-CoV-2 P.1 variant after two doses of the BNT162b2 mRNA COVID-19 vaccine.
Collapse
Affiliation(s)
- Marco Fabiani
- Human Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.V.); (A.M.); (C.G.)
| | - Katia Margiotti
- Human Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.V.); (A.M.); (C.G.)
- Correspondence: ; Tel.: +39-06-850-5805; Fax: +39-06-850-5815
| | - Antonella Viola
- Human Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.V.); (A.M.); (C.G.)
| | - Alvaro Mesoraca
- Human Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.V.); (A.M.); (C.G.)
| | - Claudio Giorlandino
- Human Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, Italy; (M.F.); (A.V.); (A.M.); (C.G.)
- Department of Biochemistry, ALTAMEDICA, Viale Liegi 45, 00198 Rome, Italy
- Department of Prenatal Diagnosis, Fetal-Maternal Medical Centre, ALTAMEDICA, Viale Liegi 45, 00198 Rome, Italy
| |
Collapse
|
13
|
Libotte F, Carpineto SL, Dello Russo C, Viola A, Margiotti K, Restaldi F, Novelli A, Mesoraca A, Giorlandino C. Cytogenetics and Molecular Investigations detect a Mosaic Variant of Turner Syndrome only Suspected by Non-Invasive Prenatal Testing: Two Case Reports with Negative Ultrasound Examinations. J Med Life 2021; 13:624-628. [PMID: 33456614 PMCID: PMC7803325 DOI: 10.25122/jml-2020-0092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Prenatal testing has been moving towards non-invasive methods to determine fetal risk for genetic disorders. Numerous studies have focused the attention on common trisomies; although the detection rate (DR) for trisomy 21 is high (over 95%), the accuracy regarding the DR for trisomies 13 and 18 has come under scrutiny. The testing has been applied to sex chromosome aneuploidies, but many studies have shown that it is not as effective as it is for common trisomies. Although non-invasive prenatal test (NIPT) has become a standard screening procedure for all pregnant women, invasive sampling procedures remain important in confirming NIPT-positive findings. In the present study, we report discordant results of Turner syndrome (TS) mosaicism between NIPT and karyotyping. A 35-year-old pregnant woman underwent NIPT, and a probable risk for Xp deletion was indicated. Subsequently, amniocentesis was performed. The karyotype was identified as mos 45,X [28]/46,X,i(X)(q1.0)[5]. In the second case, a 33-year-old woman underwent amniocentesis after a positive NIPT that indicated a probable risk for monosomy X. The result was mos 45,X [8]/46,XY[8]. Since NIPT is a screening test, the possibility of false-positive or false-negative results should always be considered. We underline the importance of pre/post detailed counseling. Furthermore, women with abnormal NIPT results should undergo immediate amniocentesis that remains the only tool for a correct diagnosis of sex chromosome aneuploidies.
Collapse
Affiliation(s)
- Francesco Libotte
- Department of Genetics, Altamedica Fetal Medical Centre, Rome, Italy
| | | | | | - Antonella Viola
- Department of Genetics, Altamedica Fetal Medical Centre, Rome, Italy
| | - Katia Margiotti
- Department of Genetics, Altamedica Fetal Medical Centre, Rome, Italy
| | - Fabrizia Restaldi
- Department of Genetics, Bambino Gesù Children's Hospital, Rome, Italy
| | - Antonio Novelli
- Department of Genetics, Bambino Gesù Children's Hospital, Rome, Italy
| | - Alvaro Mesoraca
- Department of Genetics, Altamedica Fetal Medical Centre, Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Altamedica Fetal Medical Centre, Rome, Italy
| |
Collapse
|
14
|
Pasquale C, Montanino Oliva M, Benedetti M, Berlinghieri V, Bielli W, Buonomo G, Carfagna P, Costantino A, Cristofano D, Iacomino D, Lippa A, Lisi R, Ortensi I, Quinzi A, Giorlandino C, Lisi F. Assisted reproduction and Coronavirus in Italy. Eur Rev Med Pharmacol Sci 2020; 24:7512-7515. [PMID: 32706092 DOI: 10.26355/eurrev_202007_21924] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE A novel type of Coronavirus was identified in China in December 2019. The first cases of a form of pneumonia of unknown etiology were detected at the beginning of that month in Wuhan. The virus is believed to have emerged at the Wuhan Huanan Seafood Market, where transmission of a zoonotic pathogen to humans occurred. PATIENTS AND METHODS Some studies conducted in China during the epidemic report small numbers of pregnant women infected with SARS-CoV-2 and some pregnancy complications in patients with COVID-19. However, they fail to document the transplacental passage of the virus from mother to fetus. RESULTS Following the COVID-19 outbreak, guidelines for couples who are undergoing treatments of assisted reproduction have been issued by the International Federation for Fertility Societies (IFFS), the American Society for Reproductive Medicine (ASRM), the European Society of Human Reproduction and Embryology (ESHRE) and the Latin American Network of Assisted Reproduction (REDLARA). They recommend couples to discuss assisted reproduction with their doctors while those at risk or with SARS-CoV-2 should consider freezing oocytes or embryos and retransferring them later. CONCLUSIONS Other than the US, Italy is the country with the highest number of cases (197675 positives, 26644 deaths) (updated on April 26). The Italian National Transplant Centre and the Higher Institute of Health advised on March 17 to complete the cycles already started and not to start new cycles. Phase 2 will begin on 4 May with an increase in freedom of action and fertilization treatments will start again. The Society that brings together embryologists (SIERR) has issued the guidelines to be followed when this happens.
Collapse
Affiliation(s)
- C Pasquale
- Centre for Reproductive Medicine Altamedica, Rome and Milan, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Cirillo PDR, Margiotti K, Mesoraca A, Giorlandino C. Quantification of circulating microRNAs by droplet digital PCR for cancer detection. BMC Res Notes 2020; 13:351. [PMID: 32703272 PMCID: PMC7379807 DOI: 10.1186/s13104-020-05190-3] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Accepted: 07/16/2020] [Indexed: 01/20/2023] Open
Abstract
Objective Circulating cell-free microRNAs (miRNAs) which consist of short-sequence RNAs are released from cells into the blood stream and has emerged as new biomarkers in the clinical cancer diagnosis and treatment. For instance, ovarian cancer comprises one of the three major malignant tumor types in the female reproductive system. The mortality rate of this cancer is the highest among all gynecological tumors, with ovarian cancer metastasis constituting an important cause of death. Therefore, development of a diagnostic tool that enables the ovarian cancer diagnosis in earlier stages is urgent. Results We have described an efficient protocol for an accurate absolute quantification of circulating miRNAs in healthy and ovarian cancer serum samples. Our data showed that ddPCR methodology can accurately measure circulating miRNAs levels and that can be a useful tool in biomarkers discovery for ovarian cancer detection.
Collapse
Affiliation(s)
- Priscila D R Cirillo
- Human Genetics Laboratories, ALTAMEDICA, Altamedica Main Centre, Viale Liegi 45, 00198, Rome, Italy
| | - Katia Margiotti
- Human Genetics Laboratories, ALTAMEDICA, Altamedica Main Centre, Viale Liegi 45, 00198, Rome, Italy.
| | - Alvaro Mesoraca
- Human Genetics Laboratories, ALTAMEDICA, Altamedica Main Centre, Viale Liegi 45, 00198, Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, ALTAMEDICA, Fetal-Maternal Medical Centre, Viale Liegi 45, 00198, Rome, Italy
| |
Collapse
|
16
|
Mesoraca A, Margiotti K, Viola A, Cima A, Sparacino D, Giorlandino C. Evaluation of SARS-CoV-2 viral RNA in fecal samples. Virol J 2020; 17:86. [PMID: 32605577 PMCID: PMC7324771 DOI: 10.1186/s12985-020-01359-1] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Accepted: 06/23/2020] [Indexed: 12/16/2022] Open
Abstract
The need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 67% (10/15) of the cases, while 33% (5/10) of the cases were positive. After serial virus RNA testing, 73% (11/15) of the cases resulted positive to fecal specimens. In particular, 15 days after the first positive respiratory specimens test, 6 fecal specimens became positive for SARS-CoV-2 RNA, while 13 respiratory test returned negative result. In conclusion, qRT-PCR assays of fecal specimens, is an important step to control infection, suggesting that samples remained positive for SARS-CoV-2 RNA longer time then respiratory tract samples. Our results enhance the recent knowledge on this emerging infectious disease and offer suggestions for a more complete diagnostic strategy.
Collapse
Affiliation(s)
- Alvaro Mesoraca
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Artemisia SpA, Viale Liegi 45, 00198, Rome, Italy
| | - Katia Margiotti
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Artemisia SpA, Viale Liegi 45, 00198, Rome, Italy.
| | - Antonella Viola
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Artemisia SpA, Viale Liegi 45, 00198, Rome, Italy
| | - Antonella Cima
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Artemisia SpA, Viale Liegi 45, 00198, Rome, Italy
| | - Davide Sparacino
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Artemisia SpA, Viale Liegi 45, 00198, Rome, Italy
| | - Claudio Giorlandino
- ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Artemisia SpA, Viale Liegi 45, 00198, Rome, Italy
| |
Collapse
|
17
|
Libotte F, Bizzoco D, Gabrielli I, Mesoraca A, Cignini P, Vitale SG, Marilli I, Gulino FA, Rapisarda AMC, Giorlandino C. Pallister-Killian syndrome: Cytogenetics and molecular investigations of mosaic tetrasomy 12p in prenatal chorionic villus and in amniocytes. Strategy of prenatal diagnosis. Taiwan J Obstet Gynecol 2017; 55:863-866. [PMID: 28040135 DOI: 10.1016/j.tjog.2016.07.010] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/28/2016] [Indexed: 11/19/2022] Open
Abstract
OBJECTIVE Pallister-Killian syndrome (PKS) is a rare, sporadic genetic disorder caused by mosaic tetrasomy of the short arm of chromosome 12 (12p). Clinically, PKS is characterized by several systemic abnormalities, such as intellectual impairment, hearing loss, epilepsy, hypotonia, craniofacial dysmorphism, pigmentary skin anomalies, epilepsy, and a variety of congenital malformations. Prenatally, PKS can be suspected in the presence of ultrasound anomalies: diaphragmatic hernia, rhizomelic micromelia, hydrops fetalis, fetal overweight, ventriculomegaly in the central nervous system, congenital heart defects, or absent visualization of the stomach. In all these cases, a detailed genetic study is required. PKS is diagnosed by prenatal genetic analysis through chorionic villus sampling, genetic amniocentesis, and cordocentesis. CASE REPORT We report two cases of PKS with prenatal diagnosis of isochromosome 12p made by cytogenetic studies. The first case is of a 36-year-old pregnant woman who underwent genetic chorionic villus sampling at 13th weeks of gestation after 1st trimester prenatal ultrasound revealed clinical features of PKS: flat nasal bridge and fetal hydrops. The second case is of a 32-year-old pregnant woman with genetic amniocentesis at 17th weeks of gestation that showed mos46,XX[21]/47,XX,+i(12p) associated to PKS. CONCLUSION New molecular cytogenetic techniques array comparative genomic hybridization and fluorescence in-situ hybridization in association with conventional karyotype are pivotal innovative tools to search for chromosomic anomalies and for a complete prenatal diagnosis, especially in cases such as PKS where array comparative genomic hybridization analysis alone could not show mosaicism of i(12p).
Collapse
Affiliation(s)
- Francesco Libotte
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Domenico Bizzoco
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Ivan Gabrielli
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Alvaro Mesoraca
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Pietro Cignini
- Department of Prenatal Diagnosis, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Salvatore Giovanni Vitale
- Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
| | - Ilaria Marilli
- Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy
| | - Ferdinando Antonio Gulino
- Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy
| | | | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| |
Collapse
|
18
|
Padula F, Capriglione S, Iaconianni P, Gatti S, Lippa A, Minutolo SE, Giannarelli D, Giorlandino C. Laser-assisted hatching of human embryos: may two alternative approaches (thinning versus drilling) impact on implant rate? Lasers Med Sci 2017; 32:1663-1666. [PMID: 28547074 DOI: 10.1007/s10103-017-2242-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2015] [Accepted: 05/19/2017] [Indexed: 11/30/2022]
Affiliation(s)
- Francesco Padula
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Centre, Rome, Italy
| | - Stella Capriglione
- Department of Obstetrics and Gynaecology, Campus Bio Medico University, Via Alvaro del Portillo, 200, 00128, Rome, Italy.
| | - Paola Iaconianni
- Department of Reproductive Medicine, Altamedica, Fetal-Maternal Medical Centre, Rome, Italy
| | - Simona Gatti
- Department of Reproductive Medicine, Altamedica, Fetal-Maternal Medical Centre, Rome, Italy
| | - Assunta Lippa
- Department of Reproductive Medicine, Altamedica, Fetal-Maternal Medical Centre, Rome, Italy
| | | | - Diana Giannarelli
- Scientific Direction, Biostatistical Unit, Regina Elena National Cancer Institute, Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Centre, Rome, Italy
| |
Collapse
|
19
|
Briganti V, Luvero D, Gulia C, Piergentili R, Zaami S, Buffone EL, Vallone C, Angioli R, Giorlandino C, Signore F. A novel approach in the treatment of neonatal gastroschisis: a review of the literature and a single-center experience. J Matern Fetal Neonatal Med 2017; 31:1234-1240. [PMID: 28337935 DOI: 10.1080/14767058.2017.1311859] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Gastroschisis is a congenital abdominal wall defect and its management remains an issue. We performed a review of the literature to summarize its evaluation, management and outcome and we describe a new type of surgical reduction performed in our center without anesthesia (GA), immediately after birth, in the delivery room. Between January 2002 and March 2013, we enrolled all live born infants with gastroschisis referred to the third-level Division of Obstetrics and Gynecology "San Camillo" of Rome. Two groups of infants were identified: group 1 in which gastroschis reduction was performed by the traditional technique and group 2 in which reduction was immediately performed after birth in the delivery room without GA. Twelve infants were enrolled in group 1, and seven infants in group 2. Statistical significance was observed between the groups regarding the hospital stay, for the duration of parenteral nutrition and full oral feeds (p = .004). Survival was similar between two groups. The reduction without GA performed immediately after birth in a delivery room encourages the relationship between the mother and her child and appears to be a safe and feasible technique in a selected group of patients with simple gastroschisis defect; for this reason, it could represent a valid alternative to traditional approach.
Collapse
Affiliation(s)
- Vito Briganti
- a Department of Pediatric Surgery and Urology , Azienda Ospedaliera San Camillo-Forlanini , Rome , Italy
| | - Daniela Luvero
- b Department of Medicine, Unit of Gynaecology and Obstetrics , Università Campus Bio-Medico di Roma , Rome , Italy
| | - Caterina Gulia
- c Department of Urologic and Gynaecologic Sciences , Policlinico Umberto I, Sapienza - University of Rome , Italy
| | - Roberto Piergentili
- d Institute of Molecular Biology and Pathology, National Research Council , Department of Biology and Biotechnologies , Sapienza - University of Rome , Italy
| | - Simona Zaami
- e Department of Anatomical, Histological Forensic and Orthopaedic Sciences , Sapienza - University of Rome , Italy
| | - Elsa Laura Buffone
- f Department of Neonatal Intensive Care , Azienda Ospedaliera San Camillo-Forlanini , Rome , Italy
| | - Cristina Vallone
- g Department of Gynaecology , Azienda Ospedaliera San Camillo-Forlanini , Rome , Italy
| | - Roberto Angioli
- b Department of Medicine, Unit of Gynaecology and Obstetrics , Università Campus Bio-Medico di Roma , Rome , Italy
| | - Claudio Giorlandino
- h Department of Obstetrics and Gynecology , Altamedica Main Center , Rome , Italy
| | - Fabrizio Signore
- g Department of Gynaecology , Azienda Ospedaliera San Camillo-Forlanini , Rome , Italy
| |
Collapse
|
20
|
Padula F, Laganà AS, Vitale SG, D'Emidio L, Coco C, Giannarelli D, Cariola M, Favilli A, Giorlandino C. The introduction of the absolute risk for the detection of fetal aneuploidies in the first-trimester screening. J Matern Fetal Neonatal Med 2016; 30:1249-1253. [PMID: 27442264 DOI: 10.1080/14767058.2016.1210123] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
PURPOSE Maternal age is a crucial factor in fetal aneuploidy screening, resulting in an increased rate of false-positive cases in older women and false-negative cases in younger women. The absolute risk (AR) is the simplest way to eliminate the background maternal age risk, as it represents the amount of improvement of the combined risk from the maternal background risk. The aim of this work is to assess the performance of the AR in the combined first-trimester screening for aneuploidies. MATERIALS AND METHODS A retrospective validation of the AR in the combined first-trimester screening for fetal aneuploidies, in an unselected population at Altamedica Fetal-Maternal Medical Center in Rome, between March 2007 and December 2008. RESULTS Of 3845 women included in the study, we had a complete follow-up on 2984. We evaluated that an AR < 3 would individuate 22 of 23 cases of aneuploidy with a detection rate of 95.7% (95%CI 87.3-100), a false-positive rate of 8.7% (95%CI 7.7-9.7) and a false-negative rate of 4.3% (95%CI 0-12.7). CONCLUSIONS In our study, the AR ameliorates the detection rate for aneuploidy. Further research and a prospective study on a larger population would help us to improve the AR in detecting most cases of aneuploidy.
Collapse
Affiliation(s)
- Francesco Padula
- a Department of Prenatal Diagnosis , Altamedica Fetal-Maternal Medical Centre , Rome , Italy
| | - Antonio Simone Laganà
- b Department of Human Pathology in Adulthood and Childhood "G. Barresi" , Unit of Gynecology and Obstetrics, University of Messina , Messina , Italy
| | - Salvatore Giovanni Vitale
- b Department of Human Pathology in Adulthood and Childhood "G. Barresi" , Unit of Gynecology and Obstetrics, University of Messina , Messina , Italy
| | - Laura D'Emidio
- a Department of Prenatal Diagnosis , Altamedica Fetal-Maternal Medical Centre , Rome , Italy
| | - Claudio Coco
- a Department of Prenatal Diagnosis , Altamedica Fetal-Maternal Medical Centre , Rome , Italy
| | - Diana Giannarelli
- c Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute , Rome , Italy
| | - Maria Cariola
- d Department of General Surgery and Medical Surgical Specialties , University of Catania , Catania , Italy , and
| | - Alessandro Favilli
- e Department of Obstetrics and Gynecology , University of Perugia , Perugia , Italy
| | - Claudio Giorlandino
- a Department of Prenatal Diagnosis , Altamedica Fetal-Maternal Medical Centre , Rome , Italy
| |
Collapse
|
21
|
Padula F, Laganà AS, Vitale SG, Giorlandino C. Comment on "Customized Fetal Growth Charts for Parents' Characteristics, Race, and Parity by Quantile Regression Analysis: A Cross-sectional Multicenter Italian Study". J Ultrasound Med 2016; 35:855. [PMID: 27022187 DOI: 10.7863/ultra.16.01008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- Francesco Padula
- Department of Prenatal DiagnosisAltamedica Fetal Maternal Medical CenterRome, Italy
| | - Antonio Simone Laganà
- Unit of Gynecology and ObstetricsDepartment of Human Pathology in Adulthood andChildhood "G. Barresi"University of MessinaMessina, Italy
| | - Salvatore Giovanni Vitale
- Unit of Gynecology and ObstetricsDepartment of Human Pathology in Adulthood andChildhood "G. Barresi"University of MessinaMessina, Italy
| | - Claudio Giorlandino
- Department of Prenatal DiagnosisAltamedica Fetal Maternal Medical CenterRome, Italy
| |
Collapse
|
22
|
Padula F, Laganà AS, Vitale SG, Mangiafico L, D’Emidio L, Cignini P, Giorlandino M, Gulino FA, Capriglione S, Giorlandino C. Ultrasonographic evaluation of placental cord insertion at different gestational ages in low-risk singleton pregnancies: a predictive algorithm. Facts Views Vis Obgyn 2016; 8:3-7. [PMID: 27822346 PMCID: PMC5096422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
OBJECTIVE To evaluate the accuracy of ultrasound in visualizing placental cord insertion (PCI) at different gestational ages in order to recommend the most feasible period during pregnancy to identify it. Secondary aim was to propose a predictive algorithm for PCI visualization. METHODS We performed a single-center, prospective cohort study. We enrolled patients with singleton low-risk pregnancies who underwent fetal ultrasound scan at different gestational ages. We excluded patients with body mass index of 30 Kg/m2 or more, uterine fibroids larger than 5 cm, high-risk pregnancies, fetal weight lower than < 10° percentile or higher than > 90° percentile, increased ("deep pocket" > 80 mm) or decreased ("deep pocket" < 20 mm) amniotic fluid. RESULTS Among the 468 recruited patients, the visualization of PCI was not possible in 5.77% of the cases. Furthermore, we showed that PCI visualization was lower as the gestational age increased (p = 0.049) and more difficult in case of posterior placenta (p = 0.001). CONCLUSIONS PCI should be evaluated in the first trimester or as early as possible during the second trimester. Moreover, we propose a feasible model to predict the possibility of PCI visualization according to gestational age and uterine site of implantation.
Collapse
Affiliation(s)
- F Padula
- Department of Prenatal Diagnosis. Altamedica, Fetal-Maternal Medical Center, 00198 Rome (Italy)
| | - AS Laganà
- Unit of Gynecology and Obstetrics, Department of Human Pathology in Adulthood and Childhood “G. Barresi”. University of Messina, 98125 Messina (Italy)
| | - SG Vitale
- Unit of Gynecology and Obstetrics, Department of Human Pathology in Adulthood and Childhood “G. Barresi”. University of Messina, 98125 Messina (Italy)
| | - L Mangiafico
- Department of Prenatal Diagnosis. Altamedica, Fetal-Maternal Medical Center, 00198 Rome (Italy)
| | - L D’Emidio
- Department of Prenatal Diagnosis. Altamedica, Fetal-Maternal Medical Center, 00198 Rome (Italy)
| | - P Cignini
- Department of Prenatal Diagnosis. Altamedica, Fetal-Maternal Medical Center, 00198 Rome (Italy)
| | - M Giorlandino
- Department of Prenatal Diagnosis. Altamedica, Fetal-Maternal Medical Center, 00198 Rome (Italy)
| | - FA Gulino
- Gynaecology and Obstetrics Section. Department of Medical Surgical Specialties. University of Catania, 95100 Catania (Italy)
| | - S Capriglione
- Department of Obstetrics and Gynaecology. Campus Bio Medico University of Rome, 00128 Rome (Italy)
| | - C Giorlandino
- Department of Prenatal Diagnosis. Altamedica, Fetal-Maternal Medical Center, 00198 Rome (Italy)
| |
Collapse
|
23
|
Libotte F, Bizzoco D, Gabrielli I, Tamburrino C, Ernandez C, Carpineto L, D'Aleo MP, Cima A, Mesoraca A, Cignini P, Aloisi A, Angioli R, Vitale SG, Giorlandino C. A new case of interstitial 1q 25.3-32.1 deletion: cytogenetic analysis molecular characterization and ultrasound findings. J Prenat Med 2016; 9:8-11. [PMID: 26918092 DOI: 10.11138/jpm/2015.9.1.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
INTRODUCTION deletion of long arm of chromosome 1(1q-) is a rare condition. Clinical features include Dwarfism, severe mental retardation, microcephaly and short neck delineating the "intermediate 1q deletion syndrome". CASE REPORT we report a new case of interstitial deletion of the long arm of chromosome 1, diagnosed in a 22+3 weeks gestation fetus in which cytogenetic analysis localized a loss of genetic materials of 18Mb in the 1q25.3-32.1. Fetal ultrasound showed neurodegenerative defects resembling Dandy-Walker's syndrome and bilateral clubfoot. CONCLUSIONS clinical characteristics of our case are markedly mild. This suggests that the type and the extension of the mutation obtained through cytogenetic studies, CGH array and ultrasound evaluation should be taken into account for prognostic evaluation and management of these patients.
Collapse
Affiliation(s)
- Francesco Libotte
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Domenico Bizzoco
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Ivan Gabrielli
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Caterina Tamburrino
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Cristina Ernandez
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Lorena Carpineto
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Maria Pia D'Aleo
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Antonella Cima
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Alvaro Mesoraca
- Department of Genetics, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Pietro Cignini
- Department of Prenatal Diagnosis, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Alessia Aloisi
- Department of Obstetrics and Gynecology, Campus Biomedico University, Rome, Italy
| | - Roberto Angioli
- Department of Obstetrics and Gynecology, Campus Biomedico University, Rome, Italy
| | - Salvatore Giovanni Vitale
- Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| |
Collapse
|
24
|
Cignini P, Mangiafico L, Padula F, D'Emidio L, Dugo N, Aloisi A, Giorlandino C, Vitale SG. Supplementation with a dietary multicomponent (Lafergin(®)) based on Ferric Sodium EDTA (Ferrazone(®)): results of an observational study. J Prenat Med 2016; 9:1-7. [PMID: 26918091 DOI: 10.11138/jpm/2015.9.1.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
During pregnancy, iron deficiency anemia is recognized as a specific risk factor for both adverse maternal and perinatal outcome. We decided to test the hypothesis that the daily administration of Lafergin(®), a dietary multicomponent based on Ferrazone(®) (Ferric Sodium EDTA), Lactoferrin, Vitamin C and Vitamin B12, from first trimester of pregnancy until the end of gestation, may significantly reduce, in anemic women, the severity of anemia compared to controls who received ferrous sulfate or liposomal iron.
Collapse
Affiliation(s)
- Pietro Cignini
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Lucia Mangiafico
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Francesco Padula
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Laura D'Emidio
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Nella Dugo
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Alessia Aloisi
- Department of Obstetrics and Gynecology, Campus Biomedico University of Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Salvatore Giovanni Vitale
- Department of Pediatric, Gynecological, Microbiological and Biomedical Sciences. University of Messina, Messina, Italy
| |
Collapse
|
25
|
Cignini P, Giorlandino M, Brutti P, Mangiafico L, Aloisi A, Giorlandino C. Reference Charts for Fetal Cerebellar Vermis Height: A Prospective Cross-Sectional Study of 10605 Fetuses. PLoS One 2016; 11:e0147528. [PMID: 26812238 PMCID: PMC4727931 DOI: 10.1371/journal.pone.0147528] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2015] [Accepted: 11/27/2015] [Indexed: 11/17/2022] Open
Abstract
OBJECTIVE To establish reference charts for fetal cerebellar vermis height in an unselected population. METHODS A prospective cross-sectional study between September 2009 and December 2014 was carried out at ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy. Of 25203 fetal biometric measurements, 12167 (48%) measurements of the cerebellar vermis were available. After excluding 1562 (12.8%) measurements, a total of 10605 (87.2%) fetuses were considered and analyzed once only. Parametric and nonparametric quantile regression models were used for the statistical analysis. In order to evaluate the robustness of the proposed reference charts regarding various distributional assumptions on the ultrasound measurements at hand, we compared the gestational age-specific reference curves we produced through the statistical methods used. Normal mean height based on parametric and nonparametric methods were defined for each week of gestation and the regression equation expressing the height of the cerebellar vermis as a function of gestational age was calculated. Finally the correlation between dimension/gestation was measured. RESULTS The mean height of the cerebellar vermis was 12.7mm (SD, 1.6mm; 95% confidence interval, 12.7-12.8mm). The regression equation expressing the height of the CV as a function of the gestational age was: height (mm) = -4.85+0.78 x gestational age. The correlation between dimension/gestation was expressed by the coefficient r = 0.87. CONCLUSION This is the first prospective cross-sectional study on fetal cerebellar vermis biometry with such a large sample size reported in literature. It is a detailed statistical survey and contains new centile-based reference charts for fetal height of cerebellar vermis measurements.
Collapse
Affiliation(s)
- Pietro Cignini
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Maurizio Giorlandino
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Pierpaolo Brutti
- Department of Statistics, Sapienza University of Rome, Rome, Italy
| | - Lucia Mangiafico
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| | - Alessia Aloisi
- Department of Obstetrics and Gynecology, Campus Biomedico University of Rome, Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, ALTAMEDICA Fetal-Maternal Medical Centre, Rome, Italy
| |
Collapse
|
26
|
Padula F, Giorlandino M, Capriglione S, Teodoro M, Lippa A, Minutolo S, Lena A, Lanteri A, Brutti P, D'Emidio L, Mangiafico L, Cignini P, Giorlandino C. Does the ESHRE/ESGE classification of mullerian anomalies correlate with the occurrence of pregnancy? a comparison between two definitions of myometrial thickness. Acta Med Int 2016. [DOI: 10.5530/ami.2016.1.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
27
|
Padula F, Gulino FA, Capriglione S, Giorlandino M, Cignini P, Mastrandrea ML, D'Emidio L, Giorlandino C. What Is the Rate of Incomplete Fetal Anatomic Surveys During a Second-Trimester Scan? Retrospective Observational Study of 4000 Nonobese Pregnant Women. J Ultrasound Med 2015; 34:2187-2191. [PMID: 26507696 DOI: 10.7863/ultra.15.01029] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/15/2015] [Accepted: 03/11/2015] [Indexed: 06/05/2023]
Abstract
OBJECTIVES The purpose of this study was to estimate the rate of incomplete fetal anatomic surveys during a second-trimester scan due to an unfavorable fetal position in a nonobese population. METHODS All pregnant women who came to the Altamedica Fetal-Maternal Medical Center, a specialized center for prenatal diagnosis, for a routine second-trimester scan between January 2012 and April 2013 were retrospectively included in the analysis. Patients with a body mass index higher than 30.0 kg/m(2) or anterior fibroids larger than 5 cm were not included in the study. RESULTS Of 4000 pregnant women admitted for a second-trimester scan, 169 (4.2%) came back within 2 weeks to complete the examination because of an unfavorable fetal position. In particular, 104 (2.6%) needed visualization of only 1 view, and 65 (1.6%) needed more than 1 view. The most difficult organ to visualize was the corpus callosum, in 73 cases (1.8%); the face was not visualized in 69 cases (1.7%); the cerebellar vermis was not seen in 47 fetuses (1.1%); and the heart could not be completely examined in 40 fetuses (1.0%). Of the 4000 women, 169 (4.2%) had a nonexhaustive scan; 149 (3.7%) needed a second scan to complete the second-trimester survey; 14 (0.35%) needed a third scan; and 2 (0.05%) remained with a not completely exhaustive scan. CONCLUSIONS There is always a small percentage of incomplete fetal anatomic surveys during a second-trimester scan, which cannot be modified by the sonographer's skill or by technical sonographic innovations.
Collapse
Affiliation(s)
- Francesco Padula
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Center, Rome, Italy (F.P., M.G., P.C., M.L.M., L.D., C.G.); Division of Obstetrics and Gynecology, University of Catania, Santo Bambino Hospital, Catania, Italy (F.A.G.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (S.C.).
| | - Ferdinando Antonio Gulino
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Center, Rome, Italy (F.P., M.G., P.C., M.L.M., L.D., C.G.); Division of Obstetrics and Gynecology, University of Catania, Santo Bambino Hospital, Catania, Italy (F.A.G.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (S.C.)
| | - Stella Capriglione
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Center, Rome, Italy (F.P., M.G., P.C., M.L.M., L.D., C.G.); Division of Obstetrics and Gynecology, University of Catania, Santo Bambino Hospital, Catania, Italy (F.A.G.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (S.C.)
| | - Maurizio Giorlandino
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Center, Rome, Italy (F.P., M.G., P.C., M.L.M., L.D., C.G.); Division of Obstetrics and Gynecology, University of Catania, Santo Bambino Hospital, Catania, Italy (F.A.G.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (S.C.)
| | - Pietro Cignini
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Center, Rome, Italy (F.P., M.G., P.C., M.L.M., L.D., C.G.); Division of Obstetrics and Gynecology, University of Catania, Santo Bambino Hospital, Catania, Italy (F.A.G.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (S.C.)
| | - Maria Luisa Mastrandrea
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Center, Rome, Italy (F.P., M.G., P.C., M.L.M., L.D., C.G.); Division of Obstetrics and Gynecology, University of Catania, Santo Bambino Hospital, Catania, Italy (F.A.G.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (S.C.)
| | - Laura D'Emidio
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Center, Rome, Italy (F.P., M.G., P.C., M.L.M., L.D., C.G.); Division of Obstetrics and Gynecology, University of Catania, Santo Bambino Hospital, Catania, Italy (F.A.G.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (S.C.)
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Altamedica, Fetal-Maternal Medical Center, Rome, Italy (F.P., M.G., P.C., M.L.M., L.D., C.G.); Division of Obstetrics and Gynecology, University of Catania, Santo Bambino Hospital, Catania, Italy (F.A.G.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (S.C.)
| |
Collapse
|
28
|
Cignini P, Maggio Savasta L, Gulino FA, Vitale SG, Mangiafico L, Mesoraca A, Giorlandino C. Predictive value of pregnancy-associated plasma protein-A (PAPP-A) and free beta-hCG on fetal growth restriction: results of a prospective study. Arch Gynecol Obstet 2015; 293:1227-33. [PMID: 26559420 DOI: 10.1007/s00404-015-3947-z] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2015] [Accepted: 10/23/2015] [Indexed: 02/02/2023]
Abstract
PURPOSE Low levels of plasmatic pregnancy-associated plasma protein-A (PAPP-A) and high levels of free-beta human chorionic gonadotropin (beta-hCG) could influence the outcome of pregnancy. The objective of this study is to assess the correlation between PAPP-A and free beta-hCG and birth weight. MATERIALS AND METHODS Prospective follow-up study performed on 3332 patients in the first trimester of pregnancy who were subjected to a screening test focused on evaluation of fetal aneuploidy (SCA-TEST). The values of PAPP-A and free beta-hCG were both analyzed as raw values and subsequently converted to a multiple of the median (MoM). Statistical analysis was performed using SPSS version 17.0.1 (SPSS Inc., Chicago, USA). RESULTS The incidence of "small for gestational age" in patients with PAPP-A MoM <1st and <5th ‰ was statistically significant (12 and 9.8 %; p < 0.0001). Also statistically significant data have been highlighted about free beta MoM > 95th ‰ (7 %; p = 0.03). The values of PAPP-A MoM > 99th ‰ are significantly correlated with an increased risk of "large for gestational age" (16.7 %; p < 0.0001). CONCLUSION Our study demonstrates that specific values of PAPP-A and free beta-hCG could identify the risk of low or high birth weight since the first trimester of pregnancy.
Collapse
Affiliation(s)
- Pietro Cignini
- Division of Obstetrics and Gynaecology, Altamedica Main Center, Viale Liegi, 45, Rome, Italy
| | | | - Ferdinando Antonio Gulino
- Division of Obstetrics and Gynaecology, Department of Surgery, S. Bambino Hospital, University of Catania, Via Torresino, 22, Catania, Italy.
| | - Salvatore Giovanni Vitale
- Division of Obstetrics and Gynaecology, Department of Surgery, S. Bambino Hospital, University of Catania, Via Torresino, 22, Catania, Italy
| | - Lucia Mangiafico
- Division of Obstetrics and Gynaecology, Altamedica Main Center, Viale Liegi, 45, Rome, Italy
| | - Alvaro Mesoraca
- Division of Medical Genetics, Altamedica Main Center, Viale Liegi, 45, Rome, Italy
| | | |
Collapse
|
29
|
Dello Russo C, Padula F, Di Giacomo G, Mesoraca A, Gabrielli I, Bizzoco D, Giorlandino C. A new approach for Next Generation Sequencing in prenatal diagnosis applied to a case of Charcot-Marie-Tooth syndrome. Prenat Diagn 2015; 35:1018-21. [DOI: 10.1002/pd.4627] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Revised: 05/19/2015] [Accepted: 05/23/2015] [Indexed: 11/06/2022]
Affiliation(s)
- Claudio Dello Russo
- Altamedica; Fetal-Maternal Medical Centre-Department of Human Genetics; Rome Italy
| | - Francesco Padula
- Altamedica; Fetal-Maternal Medical Centre-Department of Prenatal Diagnosis; Rome Italy
| | - Gianluca Di Giacomo
- Altamedica; Fetal-Maternal Medical Centre-Department of Human Genetics; Rome Italy
| | - Alvaro Mesoraca
- Altamedica; Fetal-Maternal Medical Centre-Department of Human Genetics; Rome Italy
| | - Ivan Gabrielli
- Altamedica; Fetal-Maternal Medical Centre-Department of Human Genetics; Rome Italy
| | - Domenico Bizzoco
- Altamedica; Fetal-Maternal Medical Centre-Department of Human Genetics; Rome Italy
| | - Claudio Giorlandino
- Altamedica; Fetal-Maternal Medical Centre-Department of Prenatal Diagnosis; Rome Italy
| |
Collapse
|
30
|
Giorlandino C, Cignini P, Padula F, Giannarelli D, d’Emidio L, Aloisi A, Plotti F, Angioli R. Effects of exogenous progesterone on fetal nuchal translucency: an observational prospective study. Am J Obstet Gynecol 2015; 212:335.e1-7. [PMID: 25305408 DOI: 10.1016/j.ajog.2014.10.003] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2014] [Revised: 09/21/2014] [Accepted: 10/06/2014] [Indexed: 10/24/2022]
Abstract
OBJECTIVE Nuchal translucency (NT) seen ultrasonographically at 11-14 weeks' gestation is a sensitive marker for Down syndrome. Despite its important role for Down syndrome screening, its use is still considered controversial due to high false-positive rates. We speculated that progesterone could lead to abnormal blood flow patterns and, subsequently, to increased NT. Our primary endpoint was to evaluate the effects of exogenous progesterone on NT thickness compared to controls. The secondary endpoint was to evaluate these effects in a subgroup at low risk for fetal aneuploidies, identifying the strongest factors influencing NT variation. The tertiary endpoint was to evaluate, within the treatment group, if there is any difference in NT according to the type of progesterone administered, route of administration, and dose regimen. STUDY DESIGN All women who came to measure NT at 11-14 weeks' gestation (crown-rump length between 45-84 mm) were considered eligible. We divided patients into 2 groups: women receiving exogenous progesterone and controls. Afterwards, 3 NT scans were performed for each case, and the largest value, accurate to 2 decimal points, was recorded. RESULTS In all, 3716 women were enrolled and analyzed. In a crude analysis, NT (P < .05) increased in the exogenous progesterone group. The same results were obtained in the low-risk group (P < .05). The factorial analysis of variance model confirmed a correlation between altered NT and gestational age (P < .0001) and progesterone exposure (P < .05). The characteristics of treatment (route, formulation, dose) were examined separately and no statistically significant differences among the subgroups were observed. CONCLUSION Exogenous progesterone increases NT.
Collapse
|
31
|
Cignini P, Padula F, Giorlandino M, Brutti P, Alfò M, Giannarelli D, Mastrandrea ML, D'Emidio L, Vacca L, Aloisi A, Giorlandino C. Reference charts for fetal corpus callosum length: a prospective cross-sectional study of 2950 fetuses. J Ultrasound Med 2014; 33:1065-1078. [PMID: 24866614 DOI: 10.7863/ultra.33.6.1065] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
OBJECTIVES The purpose of this study was to establish reference charts for fetal corpus callosum length in a convenience sample. METHODS A prospective cross-sectional study was conducted at the Artemisia Fetal-Maternal Medical Center between December 2008 and January 2012. Among 16,975 fetal biometric measurements between 19 weeks and 37 weeks 6 days' gestation, 3438 measurements of the corpus callosum (20.3%) were available. After excluding 488 measurements (14.2%), a total of 2950 fetuses (85.8%) were considered and analyzed only once. Parametric and nonparametric quantile regression models were used for the statistical analysis. To evaluate the robustness of the proposed reference charts with respect to various distributional assumptions on the sonographic measurements at hand, we compared the gestational age (GA)-specific reference curves produced by the statistical methods used. RESULTS The mean corpus callosum length was 26.18 mm (SD, 4.5 mm; 95% confidence interval, 26.01-26.34 mm). The linear regression equation expressing the length of the corpus callosum as a function of GA was length (mm) = -11.17 + 1.62 × GA. The correlation between the dimension and gestation was expressed by the coefficient r = 0.83. Normal mean lengths according the parametric and nonparametric methods were defined for each week of gestation. CONCLUSIONS This work provides new quantile-based reference charts for corpus callosum length measurements that may be useful for diagnosis of congenital corpus callosum anomalies in fetal life.
Collapse
Affiliation(s)
- Pietro Cignini
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.).
| | - Francesco Padula
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Maurizio Giorlandino
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Pierpaolo Brutti
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Marco Alfò
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Diana Giannarelli
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Maria Luisa Mastrandrea
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Laura D'Emidio
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Lorenzo Vacca
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Alessia Aloisi
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy (P.C., F.P., M.G., M.L.M., C.G.); Department of Statistics, Sapienza University of Rome, Rome, Italy (P.B., M.A.); Scientific Direction, Biostatistical Unit, Regina Elena Cancer Institute, Rome, Italy (D.G.); Department of Obstetrics and Gynecology, Catholic University of Sacred Heart, Rome, Italy (L.V.); and Department of Obstetrics and Gynecology, Campus Bio Medico, University of Rome, Rome, Italy (A.A.)
| |
Collapse
|
32
|
Padula F, Cignini P, Giannarelli D, Brizzi C, Coco C, D’Emidio L, Giorgio E, Giorlandino M, Mangiafico L, Mastrandrea M, Milite V, Mobili L, Nanni C, Raffio R, Taramanni C, Vigna R, Mesoraca A, Bizzoco D, Gabrielli I, Di Giacomo G, Barone MA, Cima A, Giorlandino FR, Emili S, Cupellaro M, Giorlandino C. Retrospective study evaluating the performance of a first-trimester combined screening for trisomy 21 in an Italian unselected population. J Prenat Med 2014; 8:50-56. [PMID: 26266002 PMCID: PMC4510564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVES to assess the performance of a combined first-trimester screening for trisomy 21 in an unselected Italian population referred to a specialized private center for prenatal medicine. METHODS a retrospective validation of first-trimester screening algorithms [risk calculation based on maternal age and nuchal translucency (NT) alone, maternal age and serum parameters (free β-hCG and PAPP-A) alone and a combination of both] for fetal aneuploidies evaluated in an unselected Italian population at Artemisia Fetal-Maternal Medical Centre in Rome. All measurements were performed between 11(+0) and 13(+6) weeks of gestation, between April 2007 and December 2008. RESULTS of 3,610 single fetuses included in the study, we had a complete follow-up on 2,984. Fourteen of 17 cases of trisomy 21 were detected when a cut-off of 1:300 was applied [detection rate (DR) 82.4%, 95% confidence interval (CI) 64.2-100; false-positive rate (FPR) 4.7%, 95% CI 3.9-5.4; false-negative rate (FNR) 17.6%, 95% CI 0-35.8%]. CONCLUSION in our study population the detection rate for trisomy 21, using the combined risk calculation based on maternal age, fetal NT, maternal PAPP-A and free β-hCG levels, was superior to the application of either parameter alone. The algorithm has been validated for first trimester screening in the Italian population.
Collapse
Affiliation(s)
- Francesco Padula
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Pietro Cignini
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Diana Giannarelli
- Scientific Direction, Biostatistical Unit, Regina Elena National Cancer Institute, Rome, Italy
| | - Cristiana Brizzi
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Claudio Coco
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Laura D’Emidio
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Elsa Giorgio
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Maurizio Giorlandino
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Lucia Mangiafico
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Marialuisa Mastrandrea
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Vincenzo Milite
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Luisa Mobili
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Cinzia Nanni
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Raffaella Raffio
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Cinzia Taramanni
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Roberto Vigna
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Alvaro Mesoraca
- Department of Genetics and Molecular Biology, Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Domenico Bizzoco
- Department of Genetics and Molecular Biology, Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Ivan Gabrielli
- Department of Genetics and Molecular Biology, Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Gianluca Di Giacomo
- Department of Genetics and Molecular Biology, Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Maria Antonietta Barone
- Department of Genetics and Molecular Biology, Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Antonella Cima
- Department of Genetics and Molecular Biology, Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | | | - Sabrina Emili
- Department of Genetics and Molecular Biology, Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Marina Cupellaro
- Department of Genetics and Molecular Biology, Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Altamedica-Artemisia Fetal-Maternal Medical Centre, Rome, Italy
| |
Collapse
|
33
|
Vitale SG, Marilli I, Cignini P, Padula F, D’Emidio L, Mangiafico L, Rapisarda AMC, Gulino FA, Cianci S, Biondi A, Giorlandino C. Comparison between modified Misgav-Ladach and Pfannenstiel-Kerr techniques for Cesarean section: review of literature. J Prenat Med 2014; 8:36-41. [PMID: 26265999 PMCID: PMC4510561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
In the last decades cesarean section rates increased in many countries becoming the most performed intraperitoneal surgical procedure. Despite its worldwide spread, a general consensus on the most appropriate technique to use has not yet been reached. The operative technique performed is made chiefly on the basis of the individual experience and preference of operators, the characteristics of patients, timing and urgency of intervention. We compared the two most known and used techniques, modified Misgav-Ladach and traditional Pfannenstiel-Kerr, and analyzed their impact on primary, short- and long-term outcomes and outcome related to health service use.
Collapse
Affiliation(s)
- Salvatore Giovanni Vitale
- Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy
| | - Ilaria Marilli
- Institute of Obstetric and Gynecologic Pathology, Department of Surgery, Division of Obstetrics and Gynecology, S. Bambino Hospital, University of Catania, Catania, Italy
| | - Pietro Cignini
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Francesco Padula
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Laura D’Emidio
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Lucia Mangiafico
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | | | - Ferdinando Antonio Gulino
- Institute of Obstetric and Gynecologic Pathology, Department of Surgery, Division of Obstetrics and Gynecology, S. Bambino Hospital, University of Catania, Catania, Italy
| | - Stefano Cianci
- Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy
| | - Antonio Biondi
- Department of Surgery, University of Catania, Catania, Italy
| | - Claudio Giorlandino
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| |
Collapse
|
34
|
Cianci S, Vitale SG, Tozzi R, Cignini P, Padula F, D’Emidio L, Mangiafico L, Giorlandino C, Frigerio L, Rossetti D, Caruso S. Tubal primary metastatic choriocarcinoma coexistent with a viable early pregnancy: a case report. J Prenat Med 2014; 8:47-49. [PMID: 26266001 PMCID: PMC4510563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
INTRODUCTION fallopian tube choriocarcinoma coexistent with viable intrauterine pregnancy is an extremely rare condition. CASE REPORT we present the first case reported in literature of tubal choriocarcinoma coexistent with viable intrauterine pregnancy detected at early gestational age (20 weeks) and successfully managed by seriate monitoring of maternal and fetal health status until 31 weeks, then treated by cesarean section followed by etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA-CO) chemotherapy protocol. CONCLUSIONS the outcome was favorable for both the mother and her fetus.
Collapse
Affiliation(s)
- Stefano Cianci
- Department of Medical Surgical Specialties, University of Catania, Catania, Italy
| | | | - Roberto Tozzi
- Department of Gynecologic Oncology, Oxford Cancer Centre, Oxford University Hospital
| | - Pietro Cignini
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Francesco Padula
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Laura D’Emidio
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Lucia Mangiafico
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Claudio Giorlandino
- Department of Gynecologic Ultrasound Imaging, Altamedica Fetal Maternal Medical Centre, Rome, Italy
| | - Luigi Frigerio
- Division of Gynecology and Obstetrics, Ospedale Papa Giovanni XXIII, Milano Bicocca University, Bergamo, Italy
| | - Diego Rossetti
- Division of Gynecology and Obstetrics, Ospedale Papa Giovanni XXIII, Milano Bicocca University, Bergamo, Italy
| | - Salvatore Caruso
- Department of Medical Surgical Specialties, University of Catania, Catania, Italy
| |
Collapse
|
35
|
Russo CD, Di Giacomo G, Cignini P, Padula F, Mangiafico L, Mesoraca A, D’Emidio L, McCluskey MR, Paganelli A, Giorlandino C. Comparative study of aCGH and Next Generation Sequencing (NGS) for chromosomal microdeletion and microduplication screening. J Prenat Med 2014; 8:57-69. [PMID: 26266003 PMCID: PMC4510565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
BACKGROUND prenatal genetic diagnosis of rare disorders is undergoing in recent years a significant enhancement through the application of methods of massive parallel sequencing. Despite the quantity and quality of the data produced, just few analytical tools and software have been developed in order to identify structural and numerical chromosomal anomalies through NGS, mostly not compatible with benchtop NGS platform and routine clinical diagnosis. METHODS we developed technical, bioinformatic, interpretive and validation pipelines for Next Generation Sequencing to identify SNPs, indels, aneuploidies, and CNVs (Copy Number Variations). RESULTS we show a new targeted resequencing approach applied to prenatal diagnosis. For sample processing we used an enrichment method for 4,813 genes library preparation; after sequencing our bioinformatic pipelines allowed both SNPs analysis for approximately thirty diseases or diseases family involved in fetus development and numerical chromosomal anomalies screening. CONCLUSIONS results obtained are compatible with those obtained through the gold standard technique, aCGH array, moreover allowing identification of genes involved in chromosome deletions or duplications and exclusion of point mutation on allele not affected by chromosome aberrations.
Collapse
Affiliation(s)
| | | | - Pietro Cignini
- Department of Fetal Maternal Medicine, Altamedica-Artemisia, Rome, Italy
| | - Francesco Padula
- Department of Fetal Maternal Medicine, Altamedica-Artemisia, Rome, Italy
| | - Lucia Mangiafico
- Department of Fetal Maternal Medicine, Altamedica-Artemisia, Rome, Italy
| | | | - Laura D’Emidio
- Department of Fetal Maternal Medicine, Altamedica-Artemisia, Rome, Italy
| | | | | | | |
Collapse
|
36
|
Dugo N, Padula F, Mobili L, Brizzi C, D’Emidio L, Cignini P, Mesoraca A, Bizzoco D, Cima A, Giorlandino C. Six consecutive false positive cases from cell-free fetal DNA testing in a single referring centre. J Prenat Med 2014; 8:31-35. [PMID: 25332757 PMCID: PMC4187000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
INTRODUCTION recent studies have proposed the introduction of cell-free fetal DNA testing (NIPT-Non Invasive Prenatal Testing) in routine clinical practice emphasizing its high sensibility and specificity. In any case, false positive and false negative findings may result from placental mosaicism, because cell-free fetal DNA originates mainly from placenta. CASE WE REPORT SIX CASES OF WOMEN WHO UNDERWENT CHORIONIC VILLUS SAMPLING (CVS) OR AMNIOCENTESIS TO CONFIRM THE RESULTS FROM NIPT: two Turner syndromes, two Triple X, one Patau syndrome, one Edward syndrome. RESULTS using classic cytogenetic analysis and, also, Array - Comparative Genomic Hybridization (Array CGH) the karyotype of all 5 fetuses was found to be normal. CONCLUSION results from NIPT must always be confirmed by invasive prenatal diagnosis. It is mandatory to inform the patient that the CVS and amniocentesis still represent the only form of prenatal diagnostic test available.
Collapse
Affiliation(s)
- Nella Dugo
- Department of Fetal Maternal Medicine, Altamedi-ca-Artemisia SpA, Rome
| | - Francesco Padula
- Department of Fetal Maternal Medicine, Altamedi-ca-Artemisia SpA, Rome
| | - Luisa Mobili
- Department of Fetal Maternal Medicine, Altamedi-ca-Artemisia SpA, Rome
| | - Cristiana Brizzi
- Department of Fetal Maternal Medicine, Altamedi-ca-Artemisia SpA, Rome
| | - Laura D’Emidio
- Department of Fetal Maternal Medicine, Altamedi-ca-Artemisia SpA, Rome
| | - Pietro Cignini
- Department of Fetal Maternal Medicine, Altamedi-ca-Artemisia SpA, Rome
| | | | | | | | | |
Collapse
|
37
|
Dello Russo C, Di Giacomo G, Mesoraca A, D’Emidio L, Iaconianni P, Minutolo E, Lippa A, Giorlandino C. Next generation sequencing in the identification of a rare genetic disease from preconceptional couple screening to preimplantation genetic diagnosis. J Prenat Med 2014; 8:17-24. [PMID: 25332755 PMCID: PMC4186999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
INTRODUCTION the use of Next Generation Sequencing (NGS) in the diagnosis of rare genetic pathologies is becoming ever more widespread in clinical practice. The following study reports the first case of preimplantation diagnosis through NGS of a form of LAMA2-related muscular dystrophy. CASE REPORT a couple came to our Reproductive Medicine Centre for a preconceptional genetic consultation and for advice regarding secondary infertility. The couple already had a 3-year-old child who was suffering from a form of muscular dystrophy that has yet to be genetically defined. The disease had been diagnosed at the age of 6 months. A blood sample was taken from both parents and the child in order to analyze the DNA through the Illumina NextSeq 500 platform and an enrichment protocol, Trusight One Sequencing Panel, created by Illumina for the simultaneous sequencing of the exon regions of 4,813 clinically relevant genes. This led to the identification of 2 point mutations in the LAMA2 gene, each inherited by a parent. The couple then underwent a cycle of IVF (in vitro fertilization). A preimplantation genetic diagnosis was carried out on the embryos obtained after setting up a protocol for the analysis of a point mutation in the LAMA2 gene, (this mutation has yet to be described in literature) and the normal embryos together with the recessive LAMA2-related muscular dystrophy related carriers were transferred. There were no complications during pregnancy, which terminated with a cesarean section at 39 weeks and the birth of healthy 3430-gram baby. CONCLUSIONS given its robustness, reliability and reproducibility, NGS could also be useful in prenatal diagnosis. This technique could guarantee an ample and quick analysis of the genes involved in development, making it possible to organize medical interventions during pregnancy and after birth.
Collapse
Affiliation(s)
| | | | | | - Laura D’Emidio
- Department of Fetal Maternal Medicine, Altamedica-Artemisia SpA, Rome
| | - Paola Iaconianni
- Department of Reproductive Medicine, Altamedica-Artemisia SpA, Rome
| | - Elisa Minutolo
- Department of Reproductive Medicine, Altamedica-Artemisia SpA, Rome
| | - Assunta Lippa
- Department of Reproductive Medicine, Altamedica-Artemisia SpA, Rome
| | | |
Collapse
|
38
|
Giorlandino C. Introducing the next generation sequencing in genomic amnio and villuos sampling. The so called �Next Generation Prenatal Diagnosis� (NGPD). J Prenat Med 2014. [DOI: 10.11138/jpm/2014.8.1.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
39
|
Giorlandino C, Mesoraca A, Bizzoco D, Dello Russo C, Cima A, Di Giacomo G, Cignini P, Padula F, Dugo N, D'Emidio L, Brizzi C, Raffio R, Milite V, Mangiafico L, Coco C, Carcioppolo O, Vigna R, Mastrandrea M, Mobili L. Introducing the next generation sequencing in genomic amnio and villuos sampling. The so called "Next Generation Prenatal Diagnosis" (NGPD). J Prenat Med 2014; 8:1-10. [PMID: 25332753 PMCID: PMC4187001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Affiliation(s)
- Claudio Giorlandino
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Alvaro Mesoraca
- Artemisia Fetal Maternal Medical Centre, Department of Genetics, Rome, Italy
| | - Domenico Bizzoco
- Artemisia Fetal Maternal Medical Centre, Department of Genetics, Rome, Italy
| | - Claudio Dello Russo
- Artemisia Fetal Maternal Medical Centre, Department of Genetics, Rome, Italy
| | - Antonella Cima
- Artemisia Fetal Maternal Medical Centre, Department of Genetics, Rome, Italy
| | - Gianluca Di Giacomo
- Artemisia Fetal Maternal Medical Centre, Department of Genetics, Rome, Italy
| | - Pietro Cignini
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Francesco Padula
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Nella Dugo
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Laura D'Emidio
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Cristiana Brizzi
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Raffaella Raffio
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Vincenzo Milite
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Lucia Mangiafico
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Claudio Coco
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Ornella Carcioppolo
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Roberto Vigna
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | | | - Luisa Mobili
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| |
Collapse
|
40
|
Coco M, Salvinelli F, Greco F, Trivelli M, D’Emidio L, Mesoraca A, Giorlandino C, Raffio R, Coco C. Significance of heterozygosis M34T mutation of GJB2 gene in non-syndromic congenital deafness. Retrospective analysis of 12,472 samples of amniotic fluid. J Prenat Med 2013; 7:56-58. [PMID: 24611097 PMCID: PMC3931280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
OBJECTIVE to determinate the role of heterozygosis of M34T mutation of GJB2 gene in non syndromic congenital deafness. METHODS retrospective study between March 2010 and June 2013. Molecular screening for 35delG and M34T mutations of the GJB2 gene was offered to all women undergoing to second trimester genetic amniocentesis. Patients were excluded from the study group if one of the following conditions were present: infections, fetal abnormalities, family history for congenital deafness, diagnosis of chromosomal abnormalities, and consanguinity between parents. RESULTS a total of 12.472 Caucasian women gave informed consent for this test. Seventy-seven cases were excluded. From the 12.395 amniotic fluid analysis remained, the following was found: 2 cases of 35delG homozygosis and 352 cases of heterozygous carriers (42 M34T mutation, 298 35delG mutation, 12 double heterozygosis M34T/35delG). The follow up in first year of life in the 42 newborns with heterozygosis for M34T mutation showed a mild deafness in 23 cases. CONCLUSIONS in our series, presence of heterozygosis M34T mutation is associated in more than 50% of cases to mild congenital deafness.
Collapse
Affiliation(s)
- Manuela Coco
- Department of Otorynology, University Campus Bio-medico, Rome, Italy
| | | | - Fabio Greco
- Department of Otorynology, University Campus Bio-medico, Rome, Italy
| | - Maurizio Trivelli
- Department of Otorynology, University Campus Bio-medico, Rome, Italy
| | - Laura D’Emidio
- Department of Prenatal Diagnosis, Artemisia Main Center, Rome, Italy
| | | | | | - Raffaella Raffio
- Department of Prenatal Diagnosis, Artemisia Main Center, Rome, Italy
| | - Claudio Coco
- Department of Prenatal Diagnosis, Artemisia Main Center, Rome, Italy
| |
Collapse
|
41
|
Giorlandino C, Giannarelli D. Effect of vaginally administered DHA fatty acids on pregnancy outcome in high risk pregnancies for preterm delivery: a double blinded randomised controlled trial. J Prenat Med 2013; 7:42-45. [PMID: 24175017 PMCID: PMC3808943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
OBJECTIVES to verify whether vaginally intake of docosahexaenoic acid (DHA), an n-3 long chain polyunsaturated fatty acid, would improve length of gestation and newborn birth weight in high risk pregnancies for preterm delivery. METHODS this study was a randomized, double-blind, controlled, clinical trial, including women at high risk for preterm delivery. Of 74 eligible women, 31 refused to participate and 34 were enrolled and randomized with equal chance of selection, 22 were assigned to treatment group and 21 were assigned to the control group, and received placebo. One gram of DHA was administered vaginally once a day starting from 21 (1 week of gestation until 37 weeks + 0 day). The primary endpoint was to determine the length of the pregnancy and secondary endpoint the newborn weight. RESULTS gestational age at delivery was 38.6 (SD, 1.05) weeks in the docosahexaenoic acid group and 37.6 (SD, 0.84) weeks in the placebo group (P =0.007). For women who completed the treatment and delivered at term there was a statistically difference of the weights in the two groups [3082.1 (SD, 293) gr cases vs 2699.3 (SD, 150) gr controls P <0.0001]. CONCLUSION in high risk patients for preterm delivery, the vaginal administration of a DHA increases length of gestation and newborn birth weight.
Collapse
Affiliation(s)
- Claudio Giorlandino
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | | |
Collapse
|
42
|
Sudano MC, D’Emidio L, Mangiafico L, Mobili L, Giorlandino C. Placental mesenchymal dysplasia, a case of intrauterine sudden death in a normal-sized fetus. J Prenat Med 2013; 7:9-11. [PMID: 23741541 PMCID: PMC3671814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
INTRODUCTION placental mesenchymal dysplasia (PMD) is a rare placental anomaly characterized by placentomegaly and grape-like vesicles which resemble molar pregnancy. CASE we report the case of 33-year-old woman (1-gravid) who visited our clinic at 11 weeks of gestation due to a suspected molar pregnancy. Ultrasound examination showed an enlarged placenta with multiple vesicular lesions. Maternal human chorionic gonadotropin level was normal and chorionic villus sampling showed a normal male karyotype (46 XY). The fetus exhibited no specific anomalies and fetal growth was normal during pregnancy with no signs of fetal suffering. At 31 weeks, the pregnancy ended owing to intrauterine fetal death (IUFD). The patient delivered a normal-sized male fetus (1800 g) with no definite anomalies. A pathological examination led to a diagnosis of placental mesenchymal dysplasia. CONCLUSION in the presence of placental ultrasound anomalies with no other sign of fetal suffering, the pregnancy should be considered at risk and, therefore, should be monitored carefully including the option of hospitalization.
Collapse
Affiliation(s)
- Maria Chiara Sudano
- Obstetric and Gynaecological Clinic University, Hospital Policlinico Vittorio Emanuele, Policlinico “Gaspare Rodolico” of Catania, Catania, Italy
| | - Laura D’Emidio
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Lucia Mangiafico
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Luisa Mobili
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Claudio Giorlandino
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| |
Collapse
|
43
|
Cignini P, Dugo N, Giorlandino C, Gauci R, Spata A, Capriglione S, Cafà EV. Prenatal diagnosis of a fetus with a ring chromosome 20 characterized by array-CGH. J Prenat Med 2012; 6:72-73. [PMID: 23272278 PMCID: PMC3530963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
OBJECTIVE a fetus with a ring chromosome 20 is presented. METHODS at 16 weeks' gestation, ultrasound examination evidenced no apparent structural malformation. Amniocentesis was performed for maternal anxiety. RESULTS chromosome analysis identified a ring chromosome 20 and array-CGH demonstrated that the ring including micro-deletion of the short arm in 20p13, that was extended for about 632.2 kb and a micro-deletion of the long arm in 20q13.33 region. CONCLUSION this is the first case of a ring chromosome 20 diagnosed prenatally. This reinforces the importance of offering amniocentesis with a-CGH to make more accurate prenatal diagnosis.
Collapse
Affiliation(s)
- Pietro Cignini
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy
| | - Nella Dugo
- Department of Obstetrics and Gynaecology, University of Rome “Campus Bio-Medico”, Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy
| | - Rosaria Gauci
- Department of Prenatal Diagnosis, University of Catania, Italy
| | - Anna Spata
- Department of Obstetrics and Gynaecology, University of Palermo, Italy
| | - Stella Capriglione
- Department of Obstetrics and Gynaecology, University of Rome “Campus Bio-Medico”, Rome, Italy
| | - Ester Valentina Cafà
- Department of Obstetrics and Gynaecology, University of Rome “Campus Bio-Medico”, Rome, Italy
| |
Collapse
|
44
|
Giorlandino C, Mesoraca A, Cignini P. Sudden intrauterine unexplained death: time for change. J Prenat Med 2012; 6:57-59. [PMID: 23272275 PMCID: PMC3530962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Affiliation(s)
- Claudio Giorlandino
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| | - Alvaro Mesoraca
- Artemisia Fetal Maternal Medical Centre, Department of Molecular Biology, Rome, Italy
| | - Pietro Cignini
- Artemisia Fetal Maternal Medical Centre, Department of Prenatal Diagnosis, Rome, Italy
| |
Collapse
|
45
|
Cignini P, Giorlandino C, Padula F, Dugo N, Cafà EV, Spata A. Epidemiology and risk factors of amniotic band syndrome, or ADAM sequence. J Prenat Med 2012; 6:59-63. [PMID: 23272276 PMCID: PMC3530965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Amniotic band sequence (ABS) is the term applied to a wide range of congenital anomalies, most typically limb and digital amputations and constriction rings, that occur in association with fibrous bands (1). These alterations may be associated or not with cutaneous and visceral abnormalities.This work, which is a literature review, examines several studies that relate to cases of amniotic band syndrome (SBA). In particular, our attention was focused on the causes and pathogenesis of the SBA. These for the most part are still unknown, but from what we observe in different jobs, are due to a mechanism of vascular damage. Therefore in this paper we examine chemical risk factors, like smoking, drug use, maternal hyperglycemia, mechanical risk factors such as the puncture of the amniotic sac after amniocentesis. We also speak of the altitude as a risk factor related to blood pressure, of the increased incidence of disease in primigravid, in women with a low level of education, in which the pregnancy was not planned, and then we talk of a higher incidence in young fathers and of the role of familiarity.
Collapse
Affiliation(s)
- Pietro Cignini
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy
| | - Francesco Padula
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy
| | - Nella Dugo
- Department of Obstetrics and Gynaecology, University of Rome “Campus Bio-Medico”, Rome, Italy
| | - Ester Valentina Cafà
- Department of Obstetrics and Gynaecology, University of Rome “Campus Bio-Medico”, Rome, Italy
| | - Anna Spata
- Department of Obstetrics and Gynaecology, University of Palermo, Italy
| |
Collapse
|
46
|
Cignini P, Cafà EV, Giorlandino C, Capriglione S, Spata A, Dugo N. Thyroid physiology and common diseases in pregnancy: review of literature. J Prenat Med 2012; 6:64-71. [PMID: 23272277 PMCID: PMC3530964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Thyroid diseases are common during pregnancy and an adequate treatment is important to prevent adverse maternal and fetal outcomes. Subclinical diseases are very frequent but not easily recognized without specific screening programs. In this article we try to summarize the knowledge on the physiologic change of the thyroid and pathological function during pregnancy; we also try to describe the best way of diagnosis and treatment of thyroid dysfunction.
Collapse
Affiliation(s)
- Pietro Cignini
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy
| | - Ester Valentina Cafà
- Department of Obstetrics and Gynaecology, University of Rome “Campus Bio-Medico”, Rome, Italy
| | - Claudio Giorlandino
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy
| | - Stella Capriglione
- Department of Obstetrics and Gynaecology, University of Rome “Campus Bio-Medico”, Rome, Italy
| | - Anna Spata
- Department of Obstetrics and Gynaecology, University of Palermo, Italy
| | - Nella Dugo
- Department of Obstetrics and Gynaecology, University of Rome “Campus Bio-Medico”, Rome, Italy
| |
Collapse
|
47
|
Cignini P, Mobili L, D'Emidio L, Mangiafico L, Coco C, Giorlandino C. Uterine fibroids and risk for complications following second-trimester amniocentesis. J Reprod Med 2011; 56:393-397. [PMID: 22010522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
OBJECTIVE To compare the abortion rate and preterm premature rupture of membranes (PPROM) after amniocentesis in women who have undergone antibiotic prophylaxis with uterine fibroids and control. STUDY DESIGN Retrospective study using the Antibiotic Prophylaxis before Second-Trimester Genetic Amniocentesis trial database carried out between January 1999 and December 2005 at the Artemisia Fetal-Maternal Medical Center (Rome, Italy). All women underwent antibiotic prophylaxis before amniocentesis. A follow-up within 4 weeks from the procedure was available. RESULTS A total of 2,497 of 21,219 (11.8%) women with uterine fibroids were identified. The rate of abortion was 2 of 2,497 (0.08%) in women with fibroids and 4 of 18,722 (0.03%) in women without fibroids (p = 0.42). The rate of PPROM was 4 of 2,497 (0.16%) in women with fibroids and 10 of 18,722 (0.05%) in women without fibroids (p = 0.12). CONCLUSION The risk for abortion and PPROM does not increase in the presence of uterine fibroids in women who have undergone antibiotic prophylaxis.
Collapse
Affiliation(s)
- Pietro Cignini
- Department of Prenatal Diagnosis, Artemisia Fetal-Maternal Medical Center, Rome, Italy.
| | | | | | | | | | | |
Collapse
|
48
|
Cignini P, Dinatale A, D'Emidio L, Giacobbe A, Pappalardo EM, Ermito S, Bizzoco D, Di Giacomo G, Gabrielli I, Mesoraca A, Giorlandino M, Giorlandino C. Prenatal Diagnosis of a Fetus with de novo Supernumerary Ring Chromosome 16 Characterized by Array Comparative Genomic Hybridization. AJP Rep 2011; 1:29-32. [PMID: 23705081 PMCID: PMC3653546 DOI: 10.1055/s-0031-1274512] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/03/2010] [Accepted: 11/21/2010] [Indexed: 10/25/2022] Open
Abstract
A fetus with de novo ring chromosome 16 is presented. At 20 weeks' gestation, ultrasound examination demonstrated bilateral clubfoot, bilateral renal pyelectasis, hypoplasia of the corpus callosum, and transposition of the great vessel. Amniocentesis was performed. Chromosome analysis identified a ring chromosome 16 [47,XY,r(16)] and array comparative genomic hybridization (a-CGH) demonstrated that the ring included the euchromatic portion 16p11.2. Postmortem examination confirmed prenatal findings. This is the first case of de novo ring chromosome 16 diagnosed prenatally with a new phenotypic pattern and also reinforces the importance of offering amniocentesis with a-CGH if fetal anomalies are detected.
Collapse
Affiliation(s)
- Pietro Cignini
- "Artemisia" Fetal-Maternal Medical Centre, Department of Prenatal Diagnosis, Rome
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Amorini AM, Giorlandino C, Longo S, D’Urso S, Mesoraca A, Santoro ML, Picardi M, Gullotta S, Cignini P, Lazzarino D, Lazzarino G, Tavazzi B. Metabolic profile of amniotic fluid as a biochemical tool to screen for inborn errors of metabolism and fetal anomalies. Mol Cell Biochem 2011; 359:205-16. [DOI: 10.1007/s11010-011-1015-y] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2011] [Accepted: 07/27/2011] [Indexed: 01/28/2023]
|
50
|
Perluigi M, di Domenico F, Fiorini A, Cocciolo A, Giorgi A, Foppoli C, Butterfield DA, Giorlandino M, Giorlandino C, Eugenia Schininà M, Coccia R. Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid. Proteomics Clin Appl 2011; 5:167-78. [DOI: 10.1002/prca.201000121] [Citation(s) in RCA: 77] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2010] [Revised: 12/19/2010] [Accepted: 01/20/2011] [Indexed: 12/21/2022]
|